{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":19,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":19,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"c98e8d888c40","filters":{"venue":"Future Rare Diseases"}},"results":[{"id":"W3128891271","doi":"10.2217/frd-2020-0006","title":"Transfusion of Modified Blood Components for the Treatment of Autoimmune Hemolytic Anemia: A Network Meta-Analysis","year":2021,"lang":"en","type":"article","venue":"Future Rare Diseases","topic":"Blood groups and transfusion","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Waterloo; McMaster University","funders":"","keywords":"Medicine; Incidence (geometry); Autoimmune hemolytic anemia; Adverse effect; Anemia; Randomized controlled trial; Internal medicine; Immunology; Hemoglobin; Hemolytic anemia; Meta-analysis","authors":[{"name":"Jiawen Deng","is_ca":true},{"name":"Fangwen Zhou","is_ca":true},{"name":"Chi Yi Wong","is_ca":true},{"name":"Elena Zheng","is_ca":true},{"name":"Emma Huang","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04117066970733201,"gpt":0.2736758022095728,"spread":0.2325051325022408,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00616535,0.001307314,0.007475425,0.00134466,0.000340186,0.001734395,0.00105891,0.001329251,0.002892641],"category_scores_gemma":[0.01167581,0.0005815424,0.01520396,0.001917095,0.0003745294,0.0008072678,0.000610679,0.001518255,0.0001627305],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001011747,"about_ca_system_score_gemma":0.0008398324,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002956429,"about_ca_topic_score_gemma":0.005036579,"domain_scores_codex":[0.9955286,0.002585042,0.0007764671,0.0006029367,0.0003543411,0.0001524723],"domain_scores_gemma":[0.9924211,0.00536524,0.001469046,0.0002470558,0.0003373171,0.0001603391],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.04118612,0.0001291077,0.01271978,0.09165061,0.8318623,0.0001118191,0.0000440182,0.0009722278,0.0006535469,0.0001525643,0.0008420371,0.01967591],"study_design_scores_gemma":[0.007620108,0.001217769,0.01145027,0.004319368,0.973022,0.00008184723,0.00002375636,0.0005248704,0.0001953535,0.0001803859,0.001346009,0.00001814445],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.06587329,0.930185,0.001023619,0.0005023906,0.0003716788,0.0002987871,0.0009201718,0.00005182593,0.0007731823],"genre_scores_gemma":[0.8017018,0.1927657,0.001946514,0.001174178,0.0004023349,0.0005146168,0.000997019,0.00003321052,0.0004647091],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.007475425,"threshold_uncertainty_score":0.03260589,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4413087173","doi":"10.1080/23995270.2025.2532358","title":"How I treat Rett syndrome with trofinetide: changes in dosing frequency and administration with rice cereal","year":2025,"lang":"en","type":"article","venue":"Future Rare Diseases","topic":"Genetics and Neurodevelopmental Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"ACADIA Pharmaceuticals","keywords":"Rett syndrome; Dosing; Administration (probate law); Medicine; Pharmacology; Biology; Biochemistry","authors":[{"name":"Arthur Beisang","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.003708007814534904,"gpt":0.2030145050772743,"spread":0.1993064972627394,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001216133,0.0004196221,0.0004347223,0.0003955831,0.0005394262,0.0009227712,0.0005049978,0.001680942,0.003918224],"category_scores_gemma":[0.00441721,0.000195401,0.0007793984,0.0001722628,0.0008005648,0.001527395,0.0004649471,0.002550886,0.002028531],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003851211,"about_ca_system_score_gemma":0.0005204491,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001110401,"about_ca_topic_score_gemma":0.002175071,"domain_scores_codex":[0.9993807,0.0002149817,0.00007295479,0.00008912968,0.0001727503,0.00006944359],"domain_scores_gemma":[0.9993795,0.0002176268,0.0001692985,0.00004611501,0.00006481267,0.0001226327],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"case_report","study_design_scores_codex":[0.001997483,0.001889604,0.01239354,0.001442804,0.0003291252,0.003927106,0.001281589,0.0009215776,0.02276742,0.004916742,0.09774648,0.8503865],"study_design_scores_gemma":[0.004034028,0.01619736,0.04308355,0.004829154,0.001103839,0.04108302,0.003191958,0.004103599,0.04563674,0.02395575,0.8123093,0.0004716079],"study_design_candidate":"case_report","study_design_consensus":null,"genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.3266819,0.1037888,0.07092328,0.3532287,0.01873926,0.002132815,0.0009336706,0.004547439,0.1190241],"genre_scores_gemma":[0.6329631,0.06400432,0.156937,0.1079521,0.008617464,0.001575985,0.0004599231,0.0005631561,0.02692688],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.003918224,"threshold_uncertainty_score":0.01310778,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4317212031","doi":"10.2217/frd-2022-0015","title":"The Effects of Palovarotene in Patients with Fibrodysplasia Ossificans Progressiva: A Plain Language Summary","year":2023,"lang":"en","type":"article","venue":"Future Rare Diseases","topic":"Heterotopic Ossification and Related Conditions","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hospital for Sick Children; University of Toronto; University Health Network","funders":"Daiichi Sankyo Europe; UCB Pharma; Incyte; BioCryst; Mead Johnson Nutrition; International Fibrodysplasia Ossificans Progressiva Association; Ultragenyx Pharmaceutical; Ipsen; Regeneron Pharmaceuticals; Pfizer","keywords":"Fibrodysplasia ossificans progressiva; Clinical trial; Medicine; Heterotopic bone; Myositis ossificans; Physical therapy; Bone formation; Dentistry; Surgery; Heterotopic ossification; Internal medicine","authors":[{"name":"Robert J. Pignolo","is_ca":false},{"name":"Edward C. Hsiao","is_ca":false},{"name":"Mona Al Mukaddam","is_ca":false},{"name":"Geneviève Baujat","is_ca":false},{"name":"Staffan K. Berglund","is_ca":false},{"name":"Matthew Brown","is_ca":false},{"name":"Angela M. Cheung","is_ca":true},{"name":"Carmen De Cunto","is_ca":false},{"name":"Patricia Delai","is_ca":false},{"name":"Nobuhiko Haga","is_ca":false},{"name":"Pekka Kannus","is_ca":true},{"name":"Richard Keen","is_ca":false},{"name":"Kim‐Hanh Le Quan Sang","is_ca":false},{"name":"Edna E. Mancilla","is_ca":false},{"name":"Rose Marino","is_ca":false},{"name":"Andrew Strahs","is_ca":false},{"name":"Frederick S. Kaplan","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.002490181814365724,"gpt":0.2267368739953984,"spread":0.2242466921810327,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002540622,0.0006363431,0.002556851,0.0007054402,0.0003066343,0.001908269,0.0009585379,0.001867497,0.01138827],"category_scores_gemma":[0.005632206,0.0002462782,0.002554842,0.0008860792,0.0004388432,0.001496776,0.0004218467,0.002686576,0.002203759],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008453336,"about_ca_system_score_gemma":0.001414819,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009646763,"about_ca_topic_score_gemma":0.002225185,"domain_scores_codex":[0.9987999,0.0004860972,0.0003836766,0.0000699239,0.0001940983,0.00006635703],"domain_scores_gemma":[0.9953453,0.00223506,0.001429276,0.00008219796,0.0007173733,0.0001907485],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.02166296,0.0006285372,0.002063749,0.1127798,0.001886741,0.0008164208,0.0002482052,0.0004488527,0.002304804,0.002129351,0.220044,0.6349866],"study_design_scores_gemma":[0.03264777,0.02284316,0.02171145,0.1090021,0.009409442,0.003795725,0.0008226146,0.0006966744,0.002037243,0.003986293,0.7927836,0.0002638995],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"other","genre_scores_codex":[0.007069143,0.9356372,0.0004477862,0.035711,0.006733507,0.0007852498,0.002991106,0.00007336423,0.01055158],"genre_scores_gemma":[0.05663988,0.8283737,0.002936479,0.07710445,0.01894394,0.002044518,0.003748496,0.00006900348,0.01013957],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.01138827,"threshold_uncertainty_score":0.03809756,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4406721598","doi":"10.1080/23995270.2024.2444861","title":"The effects of elafibranor in people with primary biliary cholangitis: a plain language summary","year":2025,"lang":"en","type":"article","venue":"Future Rare Diseases","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Canadian Nutrition Society; Canadian Paediatric Society; Canadian Cardiovascular Society; University of Calgary","funders":"Ipsen; Astellas Pharma; Fonds Wetenschappelijk Onderzoek; Boston Scientific Corporation; Gilead Sciences; GlaxoSmithKline; U.S. Department of Justice; AstraZeneca; Vlaamse regering; Dr. Falk Pharma; Pfizer; Novo Nordisk","keywords":"Plain language; Medicine; Primary (astronomy); General surgery; Internal medicine; Geography; Linguistics; Physics; Astrophysics; Philosophy","authors":[{"name":"Kris V. Kowdley","is_ca":false},{"name":"Christopher L. Bowlus","is_ca":false},{"name":"Cynthia Levy","is_ca":false},{"name":"Ulus Salih Akarca","is_ca":false},{"name":"Mário Reis Álvares‐da‐Silva","is_ca":false},{"name":"Pietro Andreoné","is_ca":false},{"name":"Marco Arrese","is_ca":false},{"name":"Sven Francque","is_ca":false},{"name":"Michael A. Heneghan","is_ca":false},{"name":"Pietro Invernizzi","is_ca":false},{"name":"D. I. Jones","is_ca":false},{"name":"Eric Lawitz","is_ca":false},{"name":"Marlyn J. Mayo","is_ca":false},{"name":"Mark G. Swain","is_ca":true},{"name":"Vı́ctor Vargas","is_ca":false},{"name":"John M. Vierling","is_ca":false},{"name":"Alejandra Villamil","is_ca":false},{"name":"Carol Addy","is_ca":false},{"name":"Julie Dietrich","is_ca":false},{"name":"Sarah Mazain","is_ca":false},{"name":"Bachirou Taddé","is_ca":false},{"name":"Benjamin F. Miller","is_ca":false},{"name":"Jianfen Shu","is_ca":false},{"name":"Claudia O. Zein","is_ca":false},{"name":"Carol L. Roberts","is_ca":false},{"name":"Gail E. Wright","is_ca":true},{"name":"Jörn M. Schattenberg","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.001457834398396568,"gpt":0.2084211682640114,"spread":0.2069633338656148,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00475397,0.0008580237,0.002297666,0.00149742,0.0006168073,0.003297966,0.001103743,0.003172386,0.01842196],"category_scores_gemma":[0.02208669,0.0004213959,0.00191181,0.001602908,0.0006880445,0.002610241,0.0008655657,0.004095438,0.00576982],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001730434,"about_ca_system_score_gemma":0.002474169,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003177108,"about_ca_topic_score_gemma":0.003465931,"domain_scores_codex":[0.9967547,0.001341811,0.001023733,0.0001622778,0.0005608217,0.0001566291],"domain_scores_gemma":[0.9731337,0.0168856,0.003495795,0.0002780731,0.005585305,0.0006215952],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001391673,0.0001526613,0.0009239875,0.03206199,0.0002637345,0.0003500947,0.0002991438,0.0001231673,0.0003393443,0.001517837,0.7515424,0.211034],"study_design_scores_gemma":[0.0007330772,0.001199709,0.006882688,0.05431797,0.0006269849,0.0009506156,0.0005798432,0.0001180311,0.0002930095,0.001739989,0.932475,0.00008322577],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"review","genre_gemma":"other","genre_scores_codex":[0.001815845,0.7706167,0.0004495042,0.1782221,0.03205965,0.0004418108,0.003023176,0.00008215321,0.01328911],"genre_scores_gemma":[0.01313221,0.7032242,0.001689864,0.2017269,0.06091223,0.00100144,0.002538596,0.0000798543,0.0156947],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.01842196,"threshold_uncertainty_score":0.06162763,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4417216476","doi":"10.1080/23995270.2025.2597031","title":"Real-world use of trofinetide: a survey of practices from prescribers at Rett syndrome centers of excellence in the United States","year":2025,"lang":"en","type":"article","venue":"Future Rare Diseases","topic":"Genetics and Neurodevelopmental Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Excellence; Rett syndrome; MEDLINE; CLARITY","authors":[{"name":"Erin Prange","is_ca":false},{"name":"David N. Lieberman","is_ca":false},{"name":"Grace Correa","is_ca":false},{"name":"Christopher W. Beatty","is_ca":false},{"name":"Arthur Beisang","is_ca":false},{"name":"Emily de los Reyes","is_ca":false},{"name":"Davut Pehli̇van","is_ca":false},{"name":"Alan K. Percy","is_ca":false},{"name":"Robin Ryther","is_ca":false},{"name":"Steven A. Skinner","is_ca":false},{"name":"Bernhard Suter","is_ca":false},{"name":"Louise Cosand","is_ca":false},{"name":"Alyssa M. Peckham","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02088355461246003,"gpt":0.2703077714047165,"spread":0.2494242167922564,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003151791,0.00009796096,0.0002309304,0.0006542543,0.0005485396,0.0008012326,0.0003584676,0.0006382609,0.001284457],"category_scores_gemma":[0.01181366,0.000266595,0.0002836018,0.0008692328,0.0005724287,0.0008630189,0.000623358,0.0007170495,0.0002130925],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001126944,"about_ca_system_score_gemma":0.001465533,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0226873,"about_ca_topic_score_gemma":0.03263649,"domain_scores_codex":[0.996516,0.001543789,0.0005785098,0.0003224975,0.0007995955,0.0002396036],"domain_scores_gemma":[0.9833452,0.004520401,0.008179021,0.000490392,0.001750195,0.001714785],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00004346125,0.00007711302,0.9864892,0.00006344511,0.00002809668,0.0001326311,0.003845866,0.00006861432,0.0002802815,0.00003702383,0.001021232,0.00791301],"study_design_scores_gemma":[0.00001215205,0.0003039595,0.9831825,0.0001466604,0.00001698647,0.0007422321,0.01276712,0.0004785218,0.0001665094,0.00002355972,0.002142476,0.00001732245],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9969422,0.0004274486,0.0001163723,0.001106215,0.000006603838,0.00003241601,0.0003500983,0.000005540191,0.001013053],"genre_scores_gemma":[0.9978718,0.000652134,0.0003267193,0.0007872992,0.000009666802,0.00002269939,0.0001882579,0.000003359354,0.0001381389],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0226873,"threshold_uncertainty_score":0.04511052,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4394716792","doi":"10.2217/frd-2023-0028","title":"The effects of garetosmab in people with fibrodysplasia ossificans progressiva (FOP): A plain language summary of the LUMINA-1 study","year":2024,"lang":"en","type":"article","venue":"Future Rare Diseases","topic":"Heterotopic Ossification and Related Conditions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Fibrodysplasia ossificans progressiva; Medicine; Plain language; Anatomy; Linguistics; Heterotopic ossification","authors":[{"name":"Maja Di Rocco","is_ca":false},{"name":"Robert J. Pignolo","is_ca":false},{"name":"Richard Keen","is_ca":false},{"name":"Dushyanth Srinivasan","is_ca":false},{"name":"Scott Mellis","is_ca":false},{"name":"Michelle Davis","is_ca":false},{"name":"Philippe Orcel","is_ca":false},{"name":"Christian Roux","is_ca":false},{"name":"Małgorzata Szczepanek","is_ca":false},{"name":"Javier Bachiller‐Corral","is_ca":false},{"name":"Angela M. Cheung","is_ca":true},{"name":"Kathryn Dahir","is_ca":false},{"name":"Mona Al Mukaddam","is_ca":false},{"name":"Anita Boyapati","is_ca":false},{"name":"Kusha Mohammadi","is_ca":false},{"name":"Aris N. Economides","is_ca":false},{"name":"Robert J. Sanchez","is_ca":false},{"name":"Dinko González Trotter","is_ca":false},{"name":"Susan Rhee","is_ca":false},{"name":"Gary Herman","is_ca":false},{"name":"Richard DelGizzi","is_ca":false},{"name":"George D. Yancopoulos","is_ca":false},{"name":"Elisabeth M. W. Eekhoff","is_ca":false},{"name":"Frederick S. Kaplan","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.002619215020641179,"gpt":0.2444963067147385,"spread":0.2418770916940973,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006674098,0.0007536996,0.003017671,0.0009905957,0.0005675112,0.002131981,0.0007312546,0.002391176,0.007749965],"category_scores_gemma":[0.0117568,0.000503678,0.004306585,0.0008989435,0.0004295091,0.001275149,0.0006619128,0.002742184,0.00130551],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009168255,"about_ca_system_score_gemma":0.001453616,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001835982,"about_ca_topic_score_gemma":0.003440717,"domain_scores_codex":[0.996412,0.001993129,0.0008199704,0.0001499997,0.0004891068,0.0001358536],"domain_scores_gemma":[0.9907329,0.005283381,0.002001697,0.0001785945,0.001258067,0.0005453267],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.09721092,0.003542666,0.00968698,0.1419766,0.01130956,0.0007271789,0.00120172,0.0003904244,0.00231415,0.001423559,0.1651306,0.5650856],"study_design_scores_gemma":[0.1723665,0.07366291,0.08056378,0.131223,0.04632558,0.002033638,0.002455078,0.0005777422,0.002241406,0.002630941,0.4853851,0.0005343435],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"other","genre_scores_codex":[0.04471548,0.8746553,0.0006475357,0.04604713,0.008050784,0.00297343,0.008461544,0.0001307558,0.01431808],"genre_scores_gemma":[0.2000677,0.677606,0.004732247,0.07553872,0.01885068,0.00568655,0.00658562,0.0001109621,0.01082152],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.007749965,"threshold_uncertainty_score":0.03529644,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W7117318193","doi":"10.1080/23995270.2025.2607961","title":"The plight of rare diseases in Southern Africa: health and social services policy recommendations","year":2025,"lang":"en","type":"article","venue":"Future Rare Diseases","topic":"Genomics and Rare Diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Aga Khan Foundation","funders":"","keywords":"Social Welfare; Health services; Social policy; Government (linguistics); Health policy; Public health","authors":[{"name":"Aneth David","is_ca":false},{"name":"Mohamed Zahir Alimohamed","is_ca":false},{"name":"Grantina Modern","is_ca":false},{"name":"Sharifa Mbarak","is_ca":true},{"name":"Husna Mad-hy","is_ca":true},{"name":"B. Ozcan","is_ca":false},{"name":"Nomsa Mtshali","is_ca":false},{"name":"Hlumela Tshijila","is_ca":false},{"name":"Kelly du Plessis","is_ca":false},{"name":"Eda Selebatso","is_ca":false},{"name":"Matshediso Letsholo","is_ca":false},{"name":"Nthabeleng Ramoeli","is_ca":false},{"name":"Trudy Nyakambangwe","is_ca":false},{"name":"Reon Van Der Merwe","is_ca":false},{"name":"Vivian Joseph","is_ca":false},{"name":"Farhan Yusuf","is_ca":false},{"name":"Maximilian Godwin Kilipamwambu","is_ca":false},{"name":"Kilaza Samson Mwaikono","is_ca":false},{"name":"Siana Nkya","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.004839057227458282,"gpt":0.2559353968020466,"spread":0.2510963395745883,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01654968,0.001872317,0.001033412,0.003195536,0.004153504,0.007628896,0.003360759,0.0236758,0.03399777],"category_scores_gemma":[0.0380937,0.0005899044,0.002756562,0.002003229,0.003336347,0.008359055,0.008803833,0.01281608,0.00370685],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.008899271,"about_ca_system_score_gemma":0.08489612,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.07714958,"about_ca_topic_score_gemma":0.06447762,"domain_scores_codex":[0.9909704,0.003475811,0.0006273215,0.0004074092,0.001558677,0.00296051],"domain_scores_gemma":[0.9665502,0.01143207,0.002044207,0.0006434832,0.006919328,0.01241077],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"theoretical_or_conceptual","study_design_scores_codex":[0.0001468871,0.00051474,0.005133674,0.002930443,0.0001152357,0.001644751,0.003348306,0.001610273,0.001068736,0.05899879,0.8372034,0.08728474],"study_design_scores_gemma":[0.0003930524,0.0002446285,0.01015494,0.01101908,0.0002323718,0.0004647738,0.009856625,0.00119236,0.0005339709,0.03696645,0.9287781,0.0001636406],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"genre_codex":"commentary","genre_gemma":"review","genre_scores_codex":[0.001718255,0.004764616,0.0005202809,0.9775109,0.004448694,0.0002613079,0.000560543,0.00009860995,0.01011683],"genre_scores_gemma":[0.05088843,0.02183388,0.01555576,0.8772285,0.006334445,0.002145822,0.001511611,0.00008904523,0.0244124],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.07714958,"threshold_uncertainty_score":0.153401,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4390113708","doi":"10.2217/frd-2023-0022","title":"Garadacimab for the prevention of hereditary angioedema attacks: a plain language summary of the VANGUARD study","year":2023,"lang":"en","type":"article","venue":"Future Rare Diseases","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St. Michael's Hospital; University of Alberta; Ottawa Allergy Research Corporation; University of Ottawa","funders":"","keywords":"Hereditary angioedema; Vanguard; Placebo; Medicine; C1-inhibitor; Angioedema; Surgery; Internal medicine; Dermatology; Alternative medicine; Pathology","authors":[{"name":"Timothy Craig","is_ca":false},{"name":"Avner Reshef","is_ca":false},{"name":"H. Henry Li","is_ca":false},{"name":"Joshua Jacobs","is_ca":false},{"name":"Jonathan A. Bernstein","is_ca":false},{"name":"Henriette Farkas","is_ca":false},{"name":"William H. Yang","is_ca":true},{"name":"Erik S.G. Stroes","is_ca":false},{"name":"Isao Ohsawa","is_ca":false},{"name":"Raffi Tachdjian","is_ca":false},{"name":"Michael Manning","is_ca":false},{"name":"William R. Lumry","is_ca":false},{"name":"Inmaculada Martinez Saguer","is_ca":false},{"name":"Emel Aygören‐Pürsün","is_ca":false},{"name":"Bruce Ritchie","is_ca":true},{"name":"Gordon Sussman","is_ca":true},{"name":"John Anderson","is_ca":false},{"name":"Kimito Kawahata","is_ca":false},{"name":"Yusuke Suzuki","is_ca":false},{"name":"Petra Staubach","is_ca":false},{"name":"Regina Treudler","is_ca":false},{"name":"Henrike Feuersenger","is_ca":false},{"name":"Lolis Wieman","is_ca":false},{"name":"Iris Jacobs","is_ca":false},{"name":"Markus Magerl","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01585118232168862,"gpt":0.2990552740792299,"spread":0.2832040917575413,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01236724,0.0009701756,0.003193586,0.001202953,0.000346176,0.003556183,0.001258521,0.002284416,0.0103253],"category_scores_gemma":[0.01527695,0.0004808699,0.003919763,0.001846811,0.000447565,0.001648468,0.0008859851,0.003170385,0.00255],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001135789,"about_ca_system_score_gemma":0.002462339,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002072118,"about_ca_topic_score_gemma":0.002112722,"domain_scores_codex":[0.9946142,0.002742306,0.001183837,0.0002881438,0.0009768561,0.0001946238],"domain_scores_gemma":[0.9889638,0.00628605,0.001830793,0.0003799917,0.001910654,0.0006286526],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.02902288,0.000590115,0.001948726,0.09194201,0.006062423,0.0003442173,0.0002606931,0.0004370184,0.001616111,0.004563651,0.2525524,0.6106597],"study_design_scores_gemma":[0.041804,0.01030455,0.01253316,0.09619051,0.0158266,0.0006869208,0.0002489474,0.0003670088,0.001059435,0.003888102,0.8168866,0.0002041779],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"other","genre_scores_codex":[0.005030886,0.9119073,0.001059224,0.04371618,0.01320004,0.002101906,0.005589698,0.0001087483,0.01728609],"genre_scores_gemma":[0.0302443,0.8442525,0.004547478,0.07547713,0.02214855,0.00372581,0.006847692,0.0001904407,0.01256614],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.01236724,"threshold_uncertainty_score":0.06540507,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W7110187874","doi":"10.1080/23995270.2025.2580913","title":"AIRLEAF <sup>®</sup> –a study of verducatib as a new kind of treatment for bronchiectasis: a plain language summary","year":2025,"lang":"en","type":"article","venue":"Future Rare Diseases","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Genentech; Grifols; Vertex Pharmaceuticals; AstraZeneca; CSL Behring; Chiesi Farmaceutici; Sanofi; Deutsche Forschungsgemeinschaft; GlaxoSmithKline; Pfizer; Bundesministerium für Bildung und Forschung; Insmed; McGill University; Gilead Sciences; Boehringer Ingelheim","keywords":"Bronchiectasis; Exacerbation; Plain language; Placebo; Disease; Pill; Lung disease; Quality of life (healthcare)","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.01042191738904794,"gpt":0.3327368808179552,"spread":0.3223149634289072,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006286788,0.0007498022,0.002039896,0.0005455615,0.0004489256,0.002917083,0.0009885136,0.002462898,0.03518908],"category_scores_gemma":[0.008986559,0.000431395,0.002476517,0.0004988991,0.000527623,0.001354748,0.0006051666,0.002915739,0.007434683],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008291762,"about_ca_system_score_gemma":0.001743375,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001345849,"about_ca_topic_score_gemma":0.002565211,"domain_scores_codex":[0.9979765,0.001107595,0.0003813849,0.0001117802,0.0003229828,0.00009971115],"domain_scores_gemma":[0.9897085,0.006520458,0.001631477,0.0001994718,0.001338851,0.0006012329],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.05010369,0.001348514,0.001362604,0.06595235,0.002430777,0.000730212,0.0003315825,0.0003754549,0.003953535,0.003272614,0.5195997,0.350539],"study_design_scores_gemma":[0.03654426,0.02996414,0.009205609,0.03640067,0.004783674,0.0007927689,0.0004627515,0.0003993573,0.002463827,0.003419786,0.8753459,0.0002172158],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"review","genre_gemma":"other","genre_scores_codex":[0.02084761,0.745128,0.001643437,0.1355284,0.03679933,0.004881068,0.01538611,0.000336145,0.03944989],"genre_scores_gemma":[0.07247771,0.5363038,0.00552784,0.2421618,0.0619472,0.00725295,0.009909865,0.0003122395,0.06410655],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.03518908,"threshold_uncertainty_score":0.1177192,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4407406073","doi":"10.1080/23995270.2025.2466383","title":"Letter in reply: orphan drugs approved in Canada: availability and additional therapeutic value","year":2025,"lang":"en","type":"article","venue":"Future Rare Diseases","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Wilfrid Laurier University; Arthur B. McDonald-Canadian Astroparticle Physics Research Institute; Fraser Institute","funders":"","keywords":"Orphan drug; Value (mathematics); Medicine; Mathematics; Biology; Bioinformatics; Statistics","authors":[{"name":"Nigel S. B. Rawson","is_ca":true},{"name":"J. F. Adams","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01325555743609485,"gpt":0.2277355903476063,"spread":0.2144800329115115,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003029895,0.0007012699,0.001860971,0.001082262,0.004145799,0.003753643,0.002501186,0.03741159,0.01060322],"category_scores_gemma":[0.03355648,0.0007143799,0.001154314,0.001331205,0.002946519,0.002952223,0.001172584,0.03390074,0.005600885],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01120344,"about_ca_system_score_gemma":0.01941563,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.1343634,"about_ca_topic_score_gemma":0.158767,"domain_scores_codex":[0.9970914,0.0004561289,0.0003768804,0.0004625719,0.001094876,0.0005181361],"domain_scores_gemma":[0.9817887,0.006691954,0.0008574413,0.0002998356,0.008070994,0.002291085],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00002116117,0.000004073101,0.0001953144,0.00002011333,0.000006141126,0.000142847,0.0000286794,0.0000137197,0.00003213761,0.0004100346,0.9978663,0.001259444],"study_design_scores_gemma":[0.00009065657,0.00002936588,0.001806917,0.0003039772,0.00004791615,0.001328061,0.0004955498,0.0002782763,0.0003006217,0.003170753,0.992015,0.0001329051],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.00015349,0.0006350816,0.00004002773,0.9847541,0.01346366,0.000007877215,0.0001538766,0.00002120129,0.0007706575],"genre_scores_gemma":[0.001787241,0.0006432952,0.0001190218,0.9821312,0.01202072,0.00001380772,0.00004451892,0.00002251348,0.003217724],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.8656366,"threshold_uncertainty_score":0.2671626,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4412069038","doi":"10.1080/23995270.2025.2515006","title":"Plain language summary: Patient journey and treatment patterns in progressive pulmonary fibrosis","year":2025,"lang":"en","type":"article","venue":"Future Rare Diseases","topic":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"Boehringer Ingelheim","keywords":"Pulmonary fibrosis; Medicine; Field (mathematics); Fibrosis; Intensive care medicine; Pathology; Mathematics","authors":[{"name":"Nazia Chaudhuri","is_ca":false},{"name":"Paolo Spagnolo","is_ca":false},{"name":"Claudia Valenzuela","is_ca":false},{"name":"Valeria C. Amatto","is_ca":true},{"name":"Oliver-Thomas Carter","is_ca":false},{"name":"Lauren Lee","is_ca":false},{"name":"Mark Small","is_ca":false},{"name":"Michael Kreuter","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.004801572897415728,"gpt":0.2532780850455136,"spread":0.2484765121480979,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002740123,0.0003567303,0.0006809073,0.002236328,0.0008605332,0.003015923,0.0006864857,0.001168621,0.02543611],"category_scores_gemma":[0.0373567,0.0001877915,0.0005240983,0.002419002,0.0004790351,0.003847738,0.001280793,0.001457388,0.004783018],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001657556,"about_ca_system_score_gemma":0.002229606,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003894697,"about_ca_topic_score_gemma":0.004308888,"domain_scores_codex":[0.9961591,0.001945811,0.0009033851,0.000176223,0.0005539742,0.0002615756],"domain_scores_gemma":[0.9761087,0.01004271,0.005289527,0.0003635401,0.006423936,0.001771581],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"observational","study_design_scores_codex":[0.0003245992,0.00008603942,0.04816655,0.004499834,0.00008613457,0.001188903,0.005834903,0.0002679529,0.0002621326,0.001062278,0.8081254,0.1300952],"study_design_scores_gemma":[0.0001309447,0.0009348693,0.1842611,0.01407106,0.000183044,0.007578201,0.03467381,0.0005930745,0.0005274647,0.001984948,0.7548178,0.0002437201],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.2005988,0.1250823,0.003600341,0.5161409,0.02266132,0.0006056662,0.06224978,0.0007129587,0.06834789],"genre_scores_gemma":[0.6625223,0.1421225,0.005670244,0.09614044,0.02063649,0.00122994,0.03560515,0.0004634719,0.0356093],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.02543611,"threshold_uncertainty_score":0.08509225,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4415687071","doi":"10.1080/23995270.2025.2570636","title":"Plain Language Summary: kidney function and severe clinical events in people with Fabry disease who receive agalsidase beta","year":2025,"lang":"en","type":"article","venue":"Future Rare Diseases","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Global Affairs Canada","funders":"Sanofi","keywords":"Fabry disease; Renal function; BETA (programming language); Kidney disease; Disease","authors":[{"name":"Julie L. Batista","is_ca":true},{"name":"Jerry Walter","is_ca":false},{"name":"Elvira Ponce","is_ca":false},{"name":"Christoph Wanner","is_ca":false},{"name":"Robert J. Desnick","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.008033434704794291,"gpt":0.2978692758426545,"spread":0.2898358411378602,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002369403,0.000957797,0.001889706,0.002057602,0.0008602746,0.003029122,0.001698779,0.002697702,0.1412666],"category_scores_gemma":[0.0442771,0.0003765187,0.001278337,0.002451176,0.0005903094,0.002747506,0.001042155,0.003330585,0.03253382],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00156298,"about_ca_system_score_gemma":0.001995769,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00755447,"about_ca_topic_score_gemma":0.006007043,"domain_scores_codex":[0.9977825,0.0008799837,0.0005749908,0.0001822823,0.0004273868,0.0001529249],"domain_scores_gemma":[0.9668372,0.01562099,0.004284657,0.0006304713,0.01086972,0.001757033],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001331541,0.0000187986,0.0008789501,0.0006362726,0.00001710941,0.00005443316,0.00003258366,0.00001786156,0.00002230665,0.0001072752,0.9924895,0.005591835],"study_design_scores_gemma":[0.0007705091,0.0004636365,0.04063448,0.01080397,0.0001610691,0.00120024,0.001243758,0.0003061155,0.0002183678,0.001303124,0.9427544,0.0001402437],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"other","genre_scores_codex":[0.008494967,0.04198856,0.001230514,0.588567,0.1733427,0.0008269448,0.1419896,0.0007648161,0.04279478],"genre_scores_gemma":[0.06124182,0.05726554,0.003234259,0.5102544,0.1656543,0.004119182,0.07852731,0.0007953921,0.1189078],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.1412666,"threshold_uncertainty_score":0.4725838,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4408500388","doi":"10.1080/23995270.2025.2466921","title":"Plain language summary of the outcomes from the first Rare Bone Disease Summit: current challenges and priority actions","year":2025,"lang":"en","type":"article","venue":"Future Rare Diseases","topic":"Genomics and Rare Diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Global Affairs Canada","funders":"","keywords":"Summit; Current (fluid); Medicine; Disease; Intensive care medicine; Geography; Engineering; Internal medicine; Cartography","authors":[{"name":"Inês Alves","is_ca":false},{"name":"Manju Chandran","is_ca":false},{"name":"Emma Albee","is_ca":false},{"name":"Michelle Davis","is_ca":false},{"name":"Edward C. Hsiao","is_ca":false},{"name":"Anna Petryk","is_ca":false},{"name":"Oliver Semler","is_ca":false},{"name":"Marwan Sleiman","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.009285446319931756,"gpt":0.2503560212204499,"spread":0.2410705749005181,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.008496929,0.001255273,0.001993726,0.003529961,0.002470695,0.009205433,0.003040343,0.005471454,0.3538853],"category_scores_gemma":[0.07861501,0.0006176993,0.002236458,0.003118364,0.0008011166,0.006055992,0.00548204,0.006506134,0.1956073],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004283405,"about_ca_system_score_gemma":0.0119682,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0116557,"about_ca_topic_score_gemma":0.01474019,"domain_scores_codex":[0.9927595,0.001792776,0.0011165,0.000384125,0.002957092,0.0009899868],"domain_scores_gemma":[0.9283887,0.01356599,0.003830863,0.001323425,0.0454006,0.00749048],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00002374795,0.000008311597,0.00005800202,0.0001944416,0.000001866724,0.00001138268,0.00001161711,0.00001047972,0.000006648605,0.00008634442,0.9905558,0.00903148],"study_design_scores_gemma":[0.00008771844,0.00004797488,0.001491234,0.002359702,0.00001586672,0.00005910174,0.0002594668,0.00004481629,0.00004507721,0.000554072,0.9950017,0.00003337383],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"other","genre_scores_codex":[0.001079996,0.01408614,0.002873217,0.4739286,0.2302651,0.002594602,0.1068309,0.003970136,0.1643714],"genre_scores_gemma":[0.01177477,0.03596117,0.006612954,0.2582113,0.1172716,0.01193872,0.1373132,0.002923649,0.4179927],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.3538853,"threshold_uncertainty_score":0.9216043,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4401784358","doi":"10.1080/23995270.2024.2380247","title":"A plain language summary of the NefIgArd trial: Nefecon for the treatment of patients with immunoglobulin A nephropathy","year":2024,"lang":"en","type":"article","venue":"Future Rare Diseases","topic":"Renal Diseases and Glomerulopathies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; University Health Network","funders":"AstraZeneca; Omeros Corporation; Alexion Pharmaceuticals; Amgen; Pfizer; GlaxoSmithKline","keywords":"Medicine; Antibody; Immunology","authors":[{"name":"Richard Lafayette","is_ca":false},{"name":"Jens Kristensen","is_ca":false},{"name":"Andrew Stone","is_ca":false},{"name":"Jürgen Floege","is_ca":false},{"name":"Vladimı́r Tesař","is_ca":false},{"name":"Hernán Trimarchi","is_ca":false},{"name":"Hong Zhang","is_ca":false},{"name":"Necmi Eren","is_ca":false},{"name":"Alexander Paliege","is_ca":false},{"name":"Heather N. Reich","is_ca":true},{"name":"Brad H. Rovin","is_ca":false},{"name":"Jonathan Barratt","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.005686959444619518,"gpt":0.2434480502845588,"spread":0.2377610908399392,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008041783,0.002010684,0.004089033,0.001613097,0.0006484897,0.005202589,0.001888525,0.005825671,0.043394],"category_scores_gemma":[0.02944123,0.0007778699,0.00489301,0.002273002,0.0004831236,0.002408393,0.0006684673,0.006974709,0.01283815],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001776427,"about_ca_system_score_gemma":0.002671879,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003010615,"about_ca_topic_score_gemma":0.003306253,"domain_scores_codex":[0.9953591,0.002336129,0.0008615481,0.0002774109,0.000863221,0.0003025141],"domain_scores_gemma":[0.9774233,0.01347915,0.00306857,0.0005280277,0.004173203,0.001327782],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.005270952,0.00009701289,0.0002883977,0.01236777,0.0009044515,0.0001214772,0.00003400202,0.0002775142,0.0002674446,0.001052547,0.9282709,0.05104751],"study_design_scores_gemma":[0.02395626,0.003002457,0.006492895,0.02436221,0.00407042,0.0003971462,0.0000994983,0.0005455232,0.0005429188,0.004798911,0.9314984,0.0002333693],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"other","genre_scores_codex":[0.003409516,0.2682495,0.004176592,0.3647219,0.1913538,0.005574204,0.1012278,0.00107809,0.06020861],"genre_scores_gemma":[0.01737677,0.2107475,0.005213619,0.4446921,0.1940828,0.009238889,0.04831834,0.0006240227,0.0697061],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.043394,"threshold_uncertainty_score":0.1451674,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4412676182","doi":"10.1080/23995270.2025.2535273","title":"A plain language summary of the phase 1/2 study of AAV5-hRKp.RPGR (botaretigene sparoparvovec) in people with RPGR-associated X-linked retinitis pigmentosa","year":2025,"lang":"en","type":"article","venue":"Future Rare Diseases","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Kellogg's (Canada)","funders":"Johnson and Johnson; Moorfields Eye Hospital NHS Foundation Trust; National Institute for Health and Care Research","keywords":"Retinitis pigmentosa; Phase (matter); Medicine; Physics; Ophthalmology","authors":[{"name":"Michel Michaelides","is_ca":false},{"name":"Cagri G. Besirli","is_ca":true},{"name":"James Bainbridge","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.003337129755909234,"gpt":0.2396379515389264,"spread":0.2363008217830172,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006921269,0.001265468,0.002077951,0.0009250887,0.0007601593,0.002444173,0.001136434,0.0027431,0.1269561],"category_scores_gemma":[0.01875784,0.0006423471,0.002509156,0.0007696273,0.0003726848,0.001311768,0.0006310456,0.002648985,0.02200722],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001369243,"about_ca_system_score_gemma":0.002860991,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003043487,"about_ca_topic_score_gemma":0.004464489,"domain_scores_codex":[0.9963606,0.001914462,0.0007569966,0.0002259262,0.0005820152,0.0001601136],"domain_scores_gemma":[0.9871727,0.006271883,0.001993353,0.0003333026,0.003353113,0.0008755808],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.01651347,0.0008074342,0.0008327027,0.02152603,0.0005903322,0.0002720485,0.0001250102,0.0002291628,0.00196282,0.001058278,0.845452,0.1106308],"study_design_scores_gemma":[0.02224693,0.01506165,0.006234549,0.0204055,0.001385188,0.0005099564,0.0001997967,0.0002091694,0.001238608,0.001676643,0.9307178,0.0001141795],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"dataset","genre_gemma":"other","genre_scores_codex":[0.01885761,0.2004831,0.01272074,0.202371,0.06818182,0.07046741,0.2475458,0.002190246,0.1771823],"genre_scores_gemma":[0.06489857,0.1853235,0.02558837,0.2816062,0.03674272,0.08600239,0.06793655,0.001374529,0.2505272],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.1269561,"threshold_uncertainty_score":0.4247105,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4407710006","doi":"10.1080/23995270.2025.2466380","title":"Orphan drugs approved in Canada: availability and additional therapeutic value","year":2025,"lang":"en","type":"article","venue":"Future Rare Diseases","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"York University; University of Toronto","funders":"","keywords":"Orphan drug; Value (mathematics); Medicine; Business; Pharmacology; Mathematics; Statistics; Biology; Bioinformatics","authors":[{"name":"Joel Lexchin","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01286622521603255,"gpt":0.2277308317862886,"spread":0.2148646065702561,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01069112,0.0004577244,0.00119361,0.004159435,0.003802922,0.008049319,0.002640884,0.005930594,0.008810005],"category_scores_gemma":[0.1018026,0.0004408882,0.0009906966,0.007305896,0.005434608,0.003817655,0.001750368,0.009934861,0.0009761848],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.05125535,"about_ca_system_score_gemma":0.09325688,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.8890666,"about_ca_topic_score_gemma":0.9242728,"domain_scores_codex":[0.9756291,0.002854817,0.001902714,0.001424085,0.0160002,0.002189085],"domain_scores_gemma":[0.85207,0.06655039,0.01168034,0.002514869,0.0621376,0.005046792],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"observational","study_design_scores_codex":[0.0001427898,0.00001405314,0.009962806,0.0003755602,0.0001137241,0.0004358785,0.0004075474,0.0003388697,0.00006787523,0.02786437,0.9232686,0.03700798],"study_design_scores_gemma":[0.0001030405,0.00003330167,0.02844431,0.002801086,0.0002631076,0.001088834,0.001733912,0.002325284,0.0004459864,0.02876884,0.933755,0.0002374054],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.003270955,0.01857755,0.000524457,0.9451312,0.01111635,0.00001583687,0.003534761,0.00002377917,0.01780507],"genre_scores_gemma":[0.2192892,0.06892092,0.002643893,0.6322477,0.06004179,0.00004195445,0.002765091,0.0001536705,0.01389585],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.1109334,"threshold_uncertainty_score":0.3718853,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4388536081","doi":"10.2217/frd-2023-0013","title":"Plain language summary of a study looking at whether genetic testing can help doctors diagnose the severity of mucopolysaccharidosis type I (MPS I)","year":2023,"lang":"en","type":"article","venue":"Future Rare Diseases","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"","keywords":"Mucopolysaccharidosis type I; Enzyme replacement therapy; Phenotype; Missense mutation; Genotype; Gene; Genetics; Mucopolysaccharidosis I; Disease; Genotype-phenotype distinction; Enzyme; Biology; Medicine; Biochemistry; Internal medicine","authors":[{"name":"L. Clarke","is_ca":true},{"name":"Roberto Giugliani","is_ca":false},{"name":"Joseph Muenzer","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02026119448871626,"gpt":0.300552782468921,"spread":0.2802915879802047,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003696214,0.0009048394,0.001803693,0.00255723,0.001263405,0.002340344,0.001145111,0.002722131,0.1779704],"category_scores_gemma":[0.0734186,0.0003734088,0.00139357,0.004307103,0.0007009853,0.002716084,0.001244945,0.002228461,0.04678453],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001937014,"about_ca_system_score_gemma":0.004034595,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01327552,"about_ca_topic_score_gemma":0.01019417,"domain_scores_codex":[0.9933894,0.002647188,0.002048538,0.0005849775,0.00100769,0.0003222721],"domain_scores_gemma":[0.9448716,0.03198762,0.005735807,0.001332707,0.01411397,0.00195824],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"observational","study_design_scores_codex":[0.0003963737,0.00003927717,0.002886426,0.004485478,0.00005627498,0.0003131208,0.0001766237,0.00003673822,0.00009478629,0.0005655081,0.9764716,0.01447774],"study_design_scores_gemma":[0.001033457,0.0004546111,0.03871069,0.02300724,0.000278875,0.001736821,0.002553388,0.0001952355,0.0002755135,0.002287275,0.9293187,0.0001481378],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"dataset","genre_gemma":"empirical","genre_scores_codex":[0.01163888,0.03190469,0.003015458,0.2451658,0.05493377,0.00337407,0.5053424,0.00122563,0.1433994],"genre_scores_gemma":[0.09975731,0.05955775,0.01108282,0.4194943,0.05953937,0.01765108,0.1829616,0.001950181,0.1480055],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.1779704,"threshold_uncertainty_score":0.5953702,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4401925418","doi":"10.1080/23995270.2024.2383163","title":"Plain Language Summary: Looking at treatment outcomes in people with Fabry disease who started agalsidase beta before the age of 30 years","year":2024,"lang":"en","type":"article","venue":"Future Rare Diseases","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Canadian Association of Gastroenterology","funders":"","keywords":"Fabry disease; Medicine; Pediatrics; BETA (programming language); Disease; Internal medicine; Computer science","authors":[{"name":"Robert J. Hopkin","is_ca":false},{"name":"Ana María Martins","is_ca":false},{"name":"Julia Alton","is_ca":true},{"name":"Camilla Tøndel","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.007470405384718379,"gpt":0.2732195483789067,"spread":0.2657491429941883,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002244035,0.0004803918,0.001057885,0.001978778,0.0005500052,0.001480935,0.0009367495,0.00176265,0.07832222],"category_scores_gemma":[0.03364188,0.0002039912,0.001713826,0.003250112,0.0002860626,0.002013812,0.0008110157,0.00142803,0.01225864],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001144016,"about_ca_system_score_gemma":0.001997762,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.007691563,"about_ca_topic_score_gemma":0.006849913,"domain_scores_codex":[0.9976775,0.0006946611,0.0007614597,0.0002127686,0.0003816156,0.0002719678],"domain_scores_gemma":[0.9791997,0.008892247,0.00542621,0.0004429607,0.004586861,0.001451993],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"observational","study_design_scores_codex":[0.001122109,0.0001111361,0.04706402,0.006967562,0.0003819174,0.0003259686,0.0003950458,0.0001439361,0.0001010167,0.0005151469,0.9100355,0.03283671],"study_design_scores_gemma":[0.002369994,0.001660707,0.5775293,0.01815784,0.001410196,0.001926158,0.005186201,0.0004498378,0.0004311789,0.002386362,0.3882087,0.0002836053],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"dataset","genre_gemma":"other","genre_scores_codex":[0.07239692,0.02725959,0.001153086,0.1678355,0.0150184,0.0008418298,0.671077,0.0005106253,0.04390712],"genre_scores_gemma":[0.3813522,0.03042609,0.004431671,0.189291,0.02184551,0.008657413,0.2987995,0.0006357873,0.06456089],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.07832222,"threshold_uncertainty_score":0.2620139,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4391262940","doi":"10.2217/frd-2023-0024","title":"Plain language summary of efanesoctocog alfa for patients with severe hemophilia A","year":2024,"lang":"en","type":"article","venue":"Future Rare Diseases","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Clotting factor; Prophylactic treatment; Clinical research; Pediatrics; Surgery; Internal medicine","authors":[{"name":"Annette von Drygalski","is_ca":false},{"name":"Pratima Chowdary","is_ca":false},{"name":"Roshni Kulkarni","is_ca":false},{"name":"Sophie Susen","is_ca":false},{"name":"Barbara A. Konkle","is_ca":false},{"name":"Johannes Oldenburg","is_ca":false},{"name":"Davide Matino","is_ca":true},{"name":"Robert Klamroth","is_ca":false},{"name":"Angela C. Weyand","is_ca":false},{"name":"Víctor Jiménez‐Yuste","is_ca":false},{"name":"Keiji Nogami","is_ca":false},{"name":"Bent Winding","is_ca":false},{"name":"Annemieke Willemze","is_ca":false},{"name":"Karin Knobe","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.006988405016050799,"gpt":0.2737567799168182,"spread":0.2667683749007674,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00133917,0.0007279221,0.00184122,0.001262448,0.0004307985,0.001640067,0.0009511884,0.001895187,0.06186657],"category_scores_gemma":[0.009919391,0.0003245175,0.0009973632,0.001233105,0.0002416663,0.001275629,0.0005384707,0.002281843,0.01747957],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000978625,"about_ca_system_score_gemma":0.001578919,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002393696,"about_ca_topic_score_gemma":0.0030129,"domain_scores_codex":[0.9987967,0.0004212853,0.0003786235,0.00007081082,0.0002628649,0.00006969226],"domain_scores_gemma":[0.9924269,0.003594163,0.001363059,0.0001003175,0.001998977,0.0005166297],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004655423,0.0000530391,0.0001578082,0.005189195,0.00004519342,0.0001090307,0.00002469028,0.00007330622,0.0001949244,0.0003011721,0.9091684,0.08421765],"study_design_scores_gemma":[0.0004866437,0.000583845,0.00264581,0.00733267,0.0001570831,0.0005521527,0.00005856347,0.00007057175,0.0001485555,0.0003444899,0.9875904,0.00002912065],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"review","genre_gemma":"other","genre_scores_codex":[0.003165302,0.5021462,0.002063569,0.2386122,0.09574594,0.001492986,0.02808685,0.0009716747,0.1277154],"genre_scores_gemma":[0.01998291,0.4730319,0.004091681,0.2735148,0.1170769,0.002403965,0.02175839,0.000419031,0.08772052],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.06186657,"threshold_uncertainty_score":0.2069643,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}